Lasaga Joseph 4
4 · RIGEL PHARMACEUTICALS INC · Filed Nov 20, 2019
Insider Transaction Report
Form 4
Lasaga Joseph
VP Bus. Dev.& Alliance Mgmt.
Transactions
- Award
Employee Stock Option (right to buy)
2019-11-18+43,750→ 43,750 totalExercise: $4.49Exp: 2028-01-24→ Common Stock (43,750 underlying)
Footnotes (1)
- [F1]The reporting person was granted a performance based option to purchase 43,750 shares of common stock on January 24, 2018. Thus, the exercise price of this option is $4.49 (the closing price of the issuer's common stock on Nasdaq the day prior to the date of grant). In light of the performance-based vesting condition of this grant, this grant was not reportable under Section 16 until the performance metric was satisfied. On November 18, 2019, it was determined that the performance metric had been met.